reviews on oral semaglutide HUGE news in the GLP-1 space! Orforglipron has outperformed in the ACHIEVE-3 clinical trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ FDA Approves Oral Semaglutide as

On Monday, the Food and Drug Administration approved a pill version of Wegovy, Novo Nordisks wildly popular weight loss drug, officially launching the first oral GLP-1 medication ever cleared for obesity treatment

In research, this combination is being studied with the PCB-157 (tissue regeneration), the Retatrutide (triple agonist metabolism) and the 5-Amino-1MQ (NNMT inhibition)

To qualify for the Ozempic gallbladder lawsuit, plaintiffs must have: #1: Taken Ozempic prior to April of 2022 #2: Have had damages as the result of taking Ozempic Damages may include loss of work hours, loss of job, medical bills, and pain and suffering

There is also a lack of definitive literature regarding the adverse effects and contraindications of GLP-1 RAs for the treatment of HS